- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0067193

About Ceza Formulations Private Limited
Data last updated:
Ceza Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1999PTC013421. Its GSTIN is 23AACCC1848B1ZA (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Narendra Kumar Dalawat and Mimoh Paliwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.6 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹50,770 (net margin 0.1%) and EBITDA of ₹36.56 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 3% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹78 Lakh and satisfied charges of ₹1.03 Cr on record.
Ceza Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0067193). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ceza-formulations-pl.business.site.
Company details
Recognitions & Rankings of Ceza Formulations
Contact details
Ceza Formulations Private Limited's registered office is in Indore, Madhya Pradesh. Its website is ceza-formulations-pl.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ceza Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ceza Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ceza Formulations Private Limited, buy the company report.
Financials of Ceza Formulations Private Limited
FY 2025 filings availableCeza Formulations Private Limited reported revenue of ₹3.6 Cr (up 50% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 50% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹50,770 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ceza Formulations Private Limited, buy the company report.
Board of directors of Ceza Formulations Private Limited
Ceza Formulations has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Kumar Dalawat | Director | 11 Jul 2016 | 10 Years 4 Months | Current |
| Mimoh Paliwal Also directs: Saji Exports LLP | Director | 10 Nov 2014 | 12 Years 0 Months | Current |
| Krishnakant Mundra Also directs: Exponential Export Solutions Private Limited | Director | 10 Nov 2014 | 12 Years 0 Months | Current |
| Anil Kumar Vyas Also directs: Mednext Pharma Private Limited, Alice Pharma Private Limited, Mednext Biotech Limited and 1 more | Director | 13 Dec 2014 | 11 Years 11 Months | Current |
Peer comparison
Ceza Formulations Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baxil Pharma Private Limited | ₹3.62 Cr (FY 2025) | -47.0% | Delhi, India | |||
| Captalo Pharma Private Limited | ₹3.61 Cr (FY 2024) | 304.0% | Ahmedabad, Gujarat, India | |||
| Ceza Formulations Private Limitedthis company | ₹3.6 Cr (FY 2024) | ₹50,770 | 0.1% | 50.0% | 8 | Indore, Madhya Pradesh, India |
| TPS Laboratories Pvt Ltd | ₹3.59 Cr (FY 2017) | -16.0% | Hyderabad, Telangana, India | |||
| Primodia Chemicals and Pharmaceuticals Private Limited | ₹3.59 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Ceza Formulations Private Limited, buy the company report.
Auditor
Ceza Formulations Private Limited is audited by Nahata Mahajan & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nahata Mahajan & Co. | FY 2023 | 009739C |
Shareholding
The shareholding of Ceza Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ceza Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Dec 2018 | 100234068 | Others | ₹78 Lakh | Open | |
| 24 Oct 2016 | 100060752 | Others | ₹92.5 Lakh | Satisfied | |
| 25 Apr 2001 | 90205691 | State Bank of India | ₹5 Lakh | Satisfied | |
| 25 Apr 2001 | 90208854 | State Bank of Indore | ₹5 Lakh | Satisfied |
To see the full charge records of Ceza Formulations Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Ceza Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ceza Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ceza Formulations Private Limited has a workforce of 8 employees on its EPFO records as of Dec 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 8 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Ceza Formulations Private Limited, buy the company report.
GST
Ceza Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCC1848B1ZA | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ceza Formulations Private Limited, buy the company report.
Recent activity
Ceza Formulations Private Limited has 12 board changes on record since 2011: 4 appointments and 8 cessations. The latest: Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016.
13 earlier events are in the company report.
Frequently asked questions
Ceza Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 1999 (27+ years old) and is registered under CIN U24232MP1999PTC013421.
Ceza Formulations has 4 current directors:
- Narendra Kumar Dalawat - Director
- Mimoh Paliwal - Director
- Krishnakant Mundra - Director
- Anil Kumar Vyas - Director
The latest financial statements of Ceza Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ceza Formulations is 23AACCC1848B1ZA, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ceza Formulations is U24232MP1999PTC013421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceza Formulations was incorporated on 26 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ceza Formulations by revenue are Baxil Pharma Private Limited, Captalo Pharma Private Limited, TPS Laboratories Pvt Ltd, Primodia Chemicals and Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016. Alex Charles Fernandes ceased to be Director on 18 Aug 2016. Narendra Kumar Dalawat was appointed as Director on 11 Jul 2016. Ceza Formulations has 12 board changes on record in total.
Yes, Ceza Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0067193).
Ceza Formulations can be reached through the website ceza-formulations-pl.business.site. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Ceza Formulations is at 236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001.

